Dr. Karoly Nikolich
Dr. Nikolich started his career in the biotech industry as a scientist at Genentech 25 years ago where he initiated and built the company’s first neuroscience research program and participated in numerous discovery and development programs. Later, he was VP Research at Lynx Therapeutics (acquired by Solexa/Illumina) and presently serves as CEO of Amnestix, Inc. Dr. Nikolich has been the US partner and advisor of Dievini, a German investment fund since 2007, supporting the portfolio companies in strategic activities. He has also co-founded several biotech companies, including AGY Therapeutics with Bob Swanson in 1998. Between 2005 and 2007, he led the Neuroscience Institute at Stanford University as its executive director. Karoly is currently also Consulting Professor at Stanford University Medical School and was formerly Adjunct Professor at the University of Southern California. As a scientist he co-authored 125 publications and was inventor of over 20 patents.
